OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts
- PMID: 20534768
- PMCID: PMC2917784
- DOI: 10.1210/jc.2010-0025
OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts
Abstract
Context: Several single-nucleotide polymorphisms (SNPs) have been reliably associated with areal bone mineral density (aBMD) in genome-wide association studies of mostly older subjects.
Objective: We aimed to test those SNPs for an association with peripheral quantitative computed tomography (pQCT) bone measures in two young cohorts.
Design and study participants: We genotyped nine SNPs from the most promising aBMD candidates in a cohort of 15-yr-olds [in the Avon Longitudinal Study of Parents and Children (ALSPAC)] and carried out association analysis with several tibial pQCT measures to determine whether these candidates were important during adolescent growth and which particular skeletal parameters each of the candidates were acting upon. We also carried out a metaanalysis of the SNPs for association with cortical bone mineral density (BMDC) in ALSPAC and a similar male-only study (Gothenburg Osteoporosis and Obesity Determinants).
Results: In the ALSPAC cohort, we found a significant association between RANK SNP (rs3018362) and BMDC but not any of the other pQCT bone measures. In the metaanalysis, we found the OPG SNP (rs4355801) and the RANK SNP (rs3018362) to be significantly associated with BMDC. We also found suggestive evidence of an association between the MARK3 SNP (rs2010281) and BMDC but with a direction of effect opposite to that previously reported.
Conclusion: The association of genes from the RANK/RANKL/OPG pathway and BMDC provides new insight into how this system might affect the skeleton, confirming it to be associated with volumetric cortical bone density but observing no relationship with bone size.
Similar articles
-
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).Mol Med Rep. 2015 May;11(5):3212-8. doi: 10.3892/mmr.2015.3152. Epub 2015 Jan 7. Mol Med Rep. 2015. PMID: 25572286 Review.
-
Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.Clin Biochem. 2013 Oct;46(15):1493-501. doi: 10.1016/j.clinbiochem.2013.03.011. Epub 2013 Mar 24. Clin Biochem. 2013. PMID: 23531404
-
Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.Calcif Tissue Int. 2011 Dec;89(6):446-55. doi: 10.1007/s00223-011-9532-y. Epub 2011 Oct 2. Calcif Tissue Int. 2011. PMID: 21964949 Free PMC article.
-
Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.J Bone Miner Res. 2010 Aug;25(8):1830-8. doi: 10.1002/jbmr.78. J Bone Miner Res. 2010. PMID: 20205168
-
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. doi: 10.1210/jc.2007-0646. Epub 2007 Sep 25. J Clin Endocrinol Metab. 2007. PMID: 17895323 Review.
Cited by
-
Endocrine Health and Health Care Disparities in the Pediatric and Sexual and Gender Minority Populations: An Endocrine Society Scientific Statement.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1533-1584. doi: 10.1210/clinem/dgad124. J Clin Endocrinol Metab. 2023. PMID: 37191578 Free PMC article.
-
Bone mineral density in high-level endurance runners: Part B-genotype-dependent characteristics.Eur J Appl Physiol. 2022 Jan;122(1):71-80. doi: 10.1007/s00421-021-04789-z. Epub 2021 Sep 22. Eur J Appl Physiol. 2022. PMID: 34550467 Free PMC article.
-
Level and change in bone microarchitectural parameters and their relationship with previous fracture and established bone mineral density loci.Bone. 2021 Jun;147:115937. doi: 10.1016/j.bone.2021.115937. Epub 2021 Mar 22. Bone. 2021. PMID: 33766802 Free PMC article.
-
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society on October 5th 2020.Front Endocrinol (Lausanne). 2021 Feb 15;11:630875. doi: 10.3389/fendo.2020.630875. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33658983 Free PMC article. Review.
-
Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis.Front Endocrinol (Lausanne). 2020 Sep 25;11:571549. doi: 10.3389/fendo.2020.571549. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33101205 Free PMC article.
References
-
- Arden NK, Baker J, Hogg C, Baan K, Spector TD 1996 The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530–534 - PubMed
-
- Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371:1505–1512 - PMC - PubMed
-
- Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513–1521 - PubMed
-
- Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11–19 - PMC - PubMed
-
- Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K 2008 Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355–2365 - PubMed